New COVID-19 drug planned for human trial for end of year by Vir, Alnylam
The companies also plan to identify up to three additional drug candidates to treat COVID-19, and potentially other coronavirus diseases.
Medical staff, wearing protective suits and face masks, work in an intensive care unit for coronavirus disease (COVID-19) patients at the Franco-Britannique hospital in Levallois-Perret near Paris as the spread of the coronavirus disease continues in France, April 15, 2020.
